(Q45131093)

9 December 2017

BRAF V600E and KRAS G12S mutations in peripheral nerve sheath tumours (English)

1 reference

9 December 2017

10

1 reference

9 December 2017

César Serrano

1

1 reference

9 December 2017

Sara Simonetti

2

1 reference

9 December 2017

Javier Hernández-Losa

3

1 reference

9 December 2017

Claudia Valverde

4

1 reference

9 December 2017

Cristina Carrato

5

1 reference

9 December 2017

Silvia Bagué

6

1 reference

9 December 2017

Ruth Orellana

7

1 reference

9 December 2017

Rosa Somoza

8

1 reference

9 December 2017

Teresa Moliné

9

1 reference

9 December 2017

Pere Huguet

11

1 reference

9 December 2017

Cleofé Romagosa

12

1 reference

9 December 2017

Santiago Ramón y Cajal

13

1 reference

9 December 2017

27 November 2012

1 reference

9 December 2017

1 reference

9 December 2017

62

1 reference

9 December 2017

3

1 reference

9 December 2017

499-504

1 reference

Aberrant regulation of ras proteins in malignant tumour cells from type 1 neurofibromatosis patients

9 December 2017

1 reference

Abnormal regulation of mammalian p21ras contributes to malignant tumor growth in von Recklinghausen (type 1) neurofibromatosis

21 January 2018

1 reference

Mechanisms in the pathogenesis of malignant tumours in neurofibromatosis type 1.

21 January 2018

1 reference

Malignant peripheral nerve sheath tumours in neurofibromatosis 1

21 January 2018

1 reference

Neurofibromatosis 1 and neurofibromatosis 2: a twenty first century perspective.

21 January 2018

1 reference

Genotype-phenotype correlations for nervous system tumors in neurofibromatosis 2: a population-based study

21 January 2018

1 reference

Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2

21 January 2018

1 reference

Merlin/neurofibromatosis type 2 suppresses growth by inhibiting the activation of Ras and Rac.

21 January 2018

1 reference

Mutations of the BRAF gene in human cancer

21 January 2018

1 reference

Schwann cell precursors from nerve innervation are a cellular origin of melanocytes in skin.

21 January 2018

1 reference

BRAF(E600) in benign and malignant human tumours

21 January 2018

1 reference

BRAF screening as a low-cost effective strategy for simplifying HNPCC genetic testing

21 January 2018

1 reference

High frequency of BRAF mutations in nevi

21 January 2018

1 reference

Germline and somatic NF1 mutations in sporadic and NF1-associated malignant peripheral nerve sheath tumours

21 January 2018

1 reference

NF1 deletions in S-100 protein-positive and negative cells of sporadic and neurofibromatosis 1 (NF1)-associated plexiform neurofibromas and malignant peripheral nerve sheath tumors

21 January 2018

1 reference

Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma

21 January 2018

1 reference

BRAFE600-associated senescence-like cell cycle arrest of human naevi

21 January 2018

1 reference

Inhibition of Mutated, Activated BRAF in Metastatic Melanoma

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/HIS.12021

1 reference

9 December 2017

1 reference